The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose escalation study of PCUR-101 in men with metastatic castration-resistant prostate cancer (mCRPC).
 
Christos Kyriakopoulos
Consulting or Advisory Role - Exelixis
Speakers' Bureau - The France Foundation
Research Funding - Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Channing Judith Paller
Consulting or Advisory Role - Dendreon
Research Funding - Lilly (Inst)
 
Ajit Verma
No Relationships to Disclose
 
Karim Kader
Employment - Pellficure; Stratifyer GmbH
Leadership - Stratify Genomics
Stock and Other Ownership Interests - Stratify Genomics
Honoraria - Pellficure
Consulting or Advisory Role - Pellficure
Speakers' Bureau - Pacific Edge Biotechnology
Patents, Royalties, Other Intellectual Property - Germline predictors of prostate cancer risk
 
Jeff Kittrelle
Employment - eFFECTOR Therapeutics; Ions Pharmaceuticals; Pellficure
Stock and Other Ownership Interests - HERON; HERON (I); Northwest Biotherapeutics; Northwest Biotherapeutics (I); Odonate Therapeutics; Odonate Therapeutics (I)
Consulting or Advisory Role - eFFECTOR Therapeutics; Ions Pharmaceuticals; Pellficure
 
Per G Borgström
Employment - Pellficure
Patents, Royalties, Other Intellectual Property - PellFiCure Pharmaceuticals, Inc.
 
Ulka N. Vaishampayan
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Genentech; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Exelixis; Novartis; Pfizer